|
SEL1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77710000048847E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.94389998226563E-09 |
| Normal-vs-Stage2 |
1.414430E-02 |
| Normal-vs-Stage3 |
3.479800E-02 |
| Normal-vs-Stage4 |
3.129500E-02 |
| Stage1-vs-Stage2 |
5.202400E-01 |
| Stage1-vs-Stage3 |
1.710590E-01 |
| Stage1-vs-Stage4 |
9.599000E-01 |
| Stage2-vs-Stage3 |
6.471400E-01 |
| Stage2-vs-Stage4 |
7.061200E-01 |
| Stage3-vs-Stage4 |
4.601600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66630004133839E-09 |
| Normal-vs-AfricanAmerican |
4.193700E-04 |
| Normal-vs-Asian |
3.107600E-02 |
| Caucasian-vs-AfricanAmerican |
4.075400E-01 |
| Caucasian-vs-Asian |
6.654600E-01 |
| AfricanAmerican-vs-Asian |
9.081200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.81470427363229E-11 |
| Normal-vs-Female |
1.593830E-01 |
| Male-vs-Female |
6.795400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.553700E-04 |
| Normal-vs-Extreme_Weight |
2.65430000201405E-09 |
| Normal-vs-Obese |
2.944000E-03 |
| Normal-vs-Extreme_Obese |
1.8966499999995E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.209600E-01 |
| Normal_Weight-vs-Obese |
4.065400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.813200E-01 |
| Extreme_Weight-vs-Obese |
5.707900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.967200E-01 |
| Obese-vs-Extreme_Obese |
2.203000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.867400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.8458000000019E-05 |
| Normal-vs-Age(61-80Yrs) |
2.55520049563529E-10 |
| Normal-vs-Age(81-100Yrs) |
7.18599999505187E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.673400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.165590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.928100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.688100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.015200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.786000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.10740347184446E-11 |
| Normal-VS-Type2 PRCC |
2.4267999999994E-05 |
| Normal-VS-KIRP CIMP |
7.325800E-01 |
| Normal-VS-Unclassified PRCC |
9.755500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.939370E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.688300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.246400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.533770E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.436400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.378800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.40809968924339E-10 |
| Normal-vs-N1 |
3.305800E-01 |
| Normal-vs-N2 |
3.062700E-03 |
| N0-vs-N1 |
3.375500E-02 |
| N0-vs-N2 |
8.824000E-01 |
| N1-vs-N2 |
3.997400E-01 |
|
|
